European Congress on Pharmacovigilance and Regulatory Affairs 2027

European-Congress-on-Pharmacovigilance-and-Regulatory-Affairs-2027

The European Congress on Pharmacovigilance and Regulatory Affairs, taking place on September 13–14, 2027, in Paris, France, is a premier international platform dedicated to advancing drug safety, pharmacovigilance, regulatory science, and patient protection through innovation, emerging technologies, and global regulatory strategies. The congress will bring together pharmacovigilance professionals, regulatory affairs specialists, clinical researchers, pharmaceutical scientists, healthcare professionals, academicians, policymakers, and industry experts to exchange knowledge, research, regulatory experiences, and emerging developments.

Under the theme “Shaping Global Drug Safety & Regulatory Science: Advanced Pharmacovigilance, AI & Innovative Regulatory Strategies,”.

Scientific Sessions

Advances in Pharmacovigilance & Regulatory Affairs
Global Trends in Drug Safety
Modern Pharmacovigilance Systems
Clinical Safety & Drug Development
Adverse Drug Reactions & Adverse Events
Signal Detection & Signal Management
AI in Pharmacovigilance
Machine Learning for Drug Safety
Predictive Pharmacovigilance & Safety Analytics
Automation in Pharmacovigilance
Natural Language Processing in Drug Safety
Real-World Data & Real-World Evidence
Pharmacoepidemiology & Drug Safety
Risk Management & Benefit-Risk Assessment
Risk Management Plans & Safety Strategies
Post-Marketing Surveillance & Safety Monitoring
Clinical Trial Safety & Pharmacovigilance
Medication Safety & Error Prevention
Patient-Centered Pharmacovigilance
Patient-Reported Outcomes & Safety Data
Regulatory Science & Innovation
Global Regulatory Affairs & Compliance
Regulatory Intelligence & Strategic Planning
International Regulatory Harmonization
Emerging Regulatory Pathways
Clinical Trial Regulations & Regulatory Strategy
Regulatory Affairs for Innovative Medicines
Biologics & Biosimilars Regulation
Gene & Cell Therapy Regulatory Affairs
Advanced Therapy Medicinal Products
Vaccine Pharmacovigilance & Safety
Personalized Medicine & Precision Pharmacovigilance
Digital Health & Pharmacovigilance
Digital Therapeutics & Regulatory Considerations
Wearable Technologies & Digital Safety Data
Decentralized Clinical Trials & Drug Safety
Data Integrity, Quality & Regulatory Compliance
Pharmacovigilance in Emerging Therapies
Translational Drug Safety & Regulatory Research
Future Directions in Pharmacovigilance & Regulatory Affairs

Important Dates
Abstract Submission Opens30/09/2026
Abstract Submission Deadline31/12/2026
Abstract Submission Closes01/01/2027
Registration Opens30/09/2026
Registration Deadline31/12/2026
Registration Closes01/01/2027
Early bird registration31/12/2026
on spot registration13/09/2027
Date formats: d/m/y
Event Details
Leave a Comment

Event Details